Challenges in diagnosis and treatment of fasciola hepatica infection

Placeholder

Publication Date

2023

Advisor

Institution Author

Ergönül, Mehmet Önder
Keske, Şiran
Pınarlık, Fatihan
Rozanes, İzzet

Co-Authors

Journal Title

Journal ISSN

Volume Title

Publisher:

DOC Design Informatics Co Ltd

Type

Journal Article
View PlumX Details

Abstract

A 57-year-old female patient presented with fever, nausea, vomiting, loss of appetite, and weight loss within the last two months. Ceftriaxone and metronidazole therapy was start-ed upon discovery of a liver abscess but provided no benefit. Following the of abscess bi-opsy, the patient developed fever, itching, anemia, acute renal failure, hyperbilirubinemia, and eosinophilia that required intensive care unit (ICU) admission. The Fasciola hepatica antibodies were detected by enzyme-linked immunosorbent assay (ELISA). Triclabendazole was started, after which the symptoms and magnetic resonance imaging (MRI) findings regressed. Even without eosinophilia, F. hepatica should be considered in cases with a liver abscess that does not respond to antibiotics.

Description

Subject

Medicine

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note